Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01712217
Title A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Astex Pharmaceuticals
Indications

lung non-small cell carcinoma

Therapies

Crizotinib

Onalespib

Age Groups: adult
Covered Countries USA | FRA | ESP | CAN

Additional content available in CKB BOOST